1887

Abstract

A routine protocol for diagnosing -associated diarrhoea (CDAD) based on both faecal-cytotoxin detection and toxigenic culture was adopted by the microbiology laboratory of the St Luc-UCL University Hospital in Brussels in 1997. A toxigenic culture is a faecal culture followed, in the case of positivity, by a direct immunoassay on colonies to detect toxin A production. The results obtained over the past 7 years in the hospital are reviewed here. A total of 10 552 diarrhoeal stools from 7042 patients were analysed, of which 9494 were negative for all tests. A total of 1058 samples (10 %) from 794 patients were culture-positive, of which 460 (4.4 %) were positive for a faecal cytotoxin. The remaining 598 cultures were tested for toxin A on colonies; 355 of them were positive, which is 3.4 % of the total, and the remaining 243 (2.3 %) were negative. The positivity of the faecal-cytotoxin assay was statistically linked to the number of colonies observed on the culture plate. In conclusion, over a 7 year period, toxigenic culture allowed the diagnosis of 355 cases of CDAD that would have been missed by a protocol using a faecal-cytotoxin assay alone. In terms of both patient care, prevention of environmental contamination and prevention of risk of a hospital outbreak, it is proposed that these results justify the recommendation to perform both faecal-toxin assay and culture in routine medical practice.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45844-0
2005-02-01
2020-10-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/2/JM540215.html?itemId=/content/journal/jmm/10.1099/jmm.0.45844-0&mimeType=html&fmt=ahah

References

  1. Alfa M. J., Kabani A., Lyerly D. & 7 other authors; 2000; Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile- associated diarrhea. J Clin Microbiol 38:2706–2714
    [Google Scholar]
  2. Barbut F., Kajzer C., Planas N., Petit J. C. 1993; Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile- associated diarrhea. J Clin Microbiol 31:963–967
    [Google Scholar]
  3. Barbut F., Lalande V., Burghoffer B., Thien H. V., Grimprel E., Petit J. C. 2002; Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 40:2079–2083 [CrossRef]
    [Google Scholar]
  4. Barbut F., Corthier G., Charpak Y. & 14 other authors; 1996; Prevalence and pathogenicity of Clostridium difficile in hospitalized patients.A French multicenter study. Arch Intern Med 156:1449–1454 [CrossRef]
    [Google Scholar]
  5. Barbut F., Delmée M., Brazier J. S. & 9 other authors; 2003; A European survey of diagnostic methods and testing protocols for Clostridium difficile . Clin Microbiol Infect 9:989–996 [CrossRef]
    [Google Scholar]
  6. Barbut F., Decré D., Burghoffer B. & 8 other authors; 1999; Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother 43:2607–2611
    [Google Scholar]
  7. Bartlett J. G. 2002; Clinical practice.Antibiotic-associated diarrhea. N Engl J Med 346:334–339 [CrossRef]
    [Google Scholar]
  8. Berrington A., Borriello S. P., Brazier J. S. & 9 other authors; 2004; National Clostridium difficile Standards Group: report to the Department of Health. J Hosp Infect 56 Suppl 1:1–38
    [Google Scholar]
  9. Brazier J. S. 1998; The diagnosis of Clostridium difficile -associated disease. J Antimicrob Chemother 41 Suppl C:29–40
    [Google Scholar]
  10. Brazier J. S. 2001; Typing of Clostridium difficile . Clin Microbiol Infect 7:428–431 [CrossRef]
    [Google Scholar]
  11. Delmée M. 2001; Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect 7:411–416 [CrossRef]
    [Google Scholar]
  12. Delmée M., Vandercam B., Avesani V., Michaux J. L. 1987; Epidemiology and prevention of Clostridium difficile infections in a leukaemia unit. Eur J Clin Microbiol 6:623–627 [CrossRef]
    [Google Scholar]
  13. Fedorko D. P., Engler H. D., O'Shaughnessy E. M., Williams E. C., Reichelderfer C. J., Smith W. I. Jr 1999; Evaluation of two rapid assays for detection of Clostridium difficile toxin A in stool specimens. J Clin Microbiol 37:3044–3047
    [Google Scholar]
  14. George W. L., Sutter V. L., Citron D., Finegold S. M. 1979; Selective and differential medium for isolation of Clostridium difficile . J Clin Microbiol 9:214–219
    [Google Scholar]
  15. Kelly C. P., LaMont J. T. 1998; Clostridium difficile infection. Annu Rev Med 49:375–390 [CrossRef]
    [Google Scholar]
  16. Kuijper E. J., de Weerdt J., Kato H., Kato N., van Dam A. P., van der Vorm E. R., Weel J., van Rheenen C., Dankert J. 2001; Nosocomial outbreak of Clostridium difficile -associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 20:528–534 [CrossRef]
    [Google Scholar]
  17. Kyne L., Sougioultzis S., McFarland L. V., Kelly C. P. 2002a; Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 23:653–659 [CrossRef]
    [Google Scholar]
  18. Kyne L., Hamel M. B., Polavaram R., Kelly C. P. 2002b; Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile . Clin Infect Dis 34:346–353 [CrossRef]
    [Google Scholar]
  19. Lozniewski A., Rabaud C., Dotto E., Weber M., Mory F. 2001; Laboratory diagnosis of Clostridium difficile -associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C.difficile strains. J Clin Microbiol 39:1996–1998 [CrossRef]
    [Google Scholar]
  20. Mulligan M. E., Rolfe R. D., Finegold S. M., George W. L. 1979; Contamination of a hospital environment by Clostridium difficile . Curr Microbiol 3:173–175 [CrossRef]
    [Google Scholar]
  21. Pelaez T., Alcala L., Alonso R., Rodriguez-Creixems M., Garcia-Lechuz J. M., Bouza E. 2002; Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother 46:1647–1650 [CrossRef]
    [Google Scholar]
  22. Samra Z., Talmor S., Bahar J. 2002; High prevalence of toxin A-negative toxin B-positive Clostridium difficile in hospitalized patients with gastrointestinal disease. Diagn Microbiol Infect Dis 43:189–192 [CrossRef]
    [Google Scholar]
  23. Thonnard J., Carreer F., Avesani V., Delmée M. 1996; Toxin A detection on Clostridium difficile colonies from 24-h cultures. Clin Microbiol Infect 2:50–54 [CrossRef]
    [Google Scholar]
  24. Wilcox M. H., Cunniffe J. G., Trundle C., Redpath C. 1996; Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 34:23–30 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45844-0
Loading
/content/journal/jmm/10.1099/jmm.0.45844-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error